Bibliography For LL-37

Every Curated Peer-Reviewed Reference Indexed For This Compound. Each Citation Can Be Exported In BibTeX, RIS, EndNote, Or Plain Text.

Indexed Types:reviewstudy

2012 - review - Pivotal Reference

A Comprehensive Summary of LL-37, the Factotum Human Cathelicidin Peptide

Vandamme D et al.. Cell Immunol.

n.d. - study

LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease.

Unknown Authors.

n.d. - study

Therapeutic effect of an MRGPRX2/MRGPRB2 antagonist on LL-37-induced rosacea-like inflammation in mice.

Unknown Authors.

n.d. - study

Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications.

Unknown Authors.

n.d. - study

The antibacterial effect of human adipose-derived stem cells on LL-37-resistant bacteria.

Unknown Authors.

n.d. - study

LL-37 as a biomarker for therapeutic response to scaling and root planing.

Unknown Authors.

n.d. - study

Design and Screening of the Peptide SAMP-12aa Derived from LL-37, Which Exhibits Anti-H. Pylori Activity and Immunomodulatory Effects.

Unknown Authors.

n.d. - study

LL-37-biofunctionalized titanium improves soft tissue seal surrounding the dental implant from the perspective of optimizing a race to the surface.

Unknown Authors.

n.d. - study

LL-37 and citrullinated-LL-37 enhances oxylipins: citrullination attenuates LL-37-mediated COX-2-dependent chemokine response in human bronchial epithelial cells.

Unknown Authors.

n.d. - study

β-Amyloid (Aβ) and Human Cathelicidin LL-37: Two Sides of the Same Coin?

Unknown Authors.

n.d. - study

Combined nonoxynol-9 and antimicrobial peptide LL-37 for barrier contraception.

Unknown Authors.

n.d. - study

Effects of Botulinum Toxin A on Rosacea-Like Inflammation in an LL-37-Induced Rosacea Mouse Model.

Unknown Authors.

n.d. - study

Aggregation-State Dynamics Drive Double Cooperativity Between Antimicrobial Peptides LL-37 and HNP1.

Unknown Authors.

n.d. - study

LL-37 selectively targets Plasmodium-infected erythrocytes and exhibits antimalarial activity.

Unknown Authors.

n.d. - study

Heteroaggregation of Antimicrobial Peptides LL-37 and HNP‑1 Drives Cooperative Neutralization of Cytotoxicity.

Unknown Authors.

n.d. - study

LL-37 IgG levels are associated with clinical characteristics and T follicular cell response in acute coronary syndrome in adults.

Unknown Authors.

n.d. - study

LL-37 Inhibits EV71 Infection by Upregulating STAC via the EGFR-ERK Signaling Pathway.

Unknown Authors.

n.d. - study

Adaptive immune response to the autoantigen LL‐37 differentiates atherosclerotic cardiovascular disease phenotypes

Unknown Authors.

n.d. - study

Dermofunctional Vehicle Downregulates LL-37 and MMPs and Upregulates IGFBP-3.

Unknown Authors.

n.d. - study

Serine protease HtrA promotes Campylobacter jejuni intestinal colonization through degrading antimicrobial peptide LL-37.

Unknown Authors.

n.d. - study

Comparing the genetic and serum expression of LL-37 Antimicrobial Peptide in pemphigus vulgaris and pemphigus foliaceus patients.

Unknown Authors.

n.d. - study

Evaluation of the relationship between salivary levels of Streptococcus mutans, statherin, and cathelicidin LL-37 and early childhood caries.

Unknown Authors.

n.d. - study

Legionella pneumophila-Induced NETs Do Not Bear LL-37 Peptides.

Unknown Authors.

n.d. - study

Assessment of Antimicrobial Activity of LL-37 Peptide Against Periapical Pathogens: A Cross-Sectional Study.

Unknown Authors.

n.d. - study

LL-37 and citrullinated-LL-37 modulate IL-17A/F-mediated responses and selectively suppress Lipocalin-2 in bronchial epithelial cells.

Unknown Authors.

n.d. - study

Optimized LL-37-Derived Peptides Exhibit Antitubercular Activity, Induce Membrane Disruption, and P-Type ATPase Transcriptional Responses in Mycobacterium tuberculosis.

Unknown Authors.

n.d. - study

Elevated LL-37/FPR2 Axis and its Regulatory Role for Gingival Fibroblasts in Periodontitis.

Unknown Authors.

n.d. - study

Structural and mechanistic divergence in LL-37, HNP-1, and Magainin-2: An integrated computational and biophysical analysis.

Unknown Authors.

n.d. - study

LAPTM5 exacerbates STING-mediated inflammation induced by LL-37 through stabilizing STING in rosacea.

Unknown Authors.

Bibliography For LL-37

A Comprehensive Summary of LL-37, the Factotum Human Cathelicidin Peptide

LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease.

Therapeutic effect of an MRGPRX2/MRGPRB2 antagonist on LL-37-induced rosacea-like inflammation in mice.

Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications.

The antibacterial effect of human adipose-derived stem cells on LL-37-resistant bacteria.

<i>LL-37</i> as a biomarker for therapeutic response to scaling and root planing.

Design and Screening of the Peptide SAMP-12aa Derived from LL-37, Which Exhibits Anti-<i>H. Pylori</i> Activity and Immunomodulatory Effects.

LL-37-biofunctionalized titanium improves soft tissue seal surrounding the dental implant from the perspective of optimizing a race to the surface.

LL-37 and citrullinated-LL-37 enhances oxylipins: citrullination attenuates LL-37-mediated COX-2-dependent chemokine response in human bronchial epithelial cells.

β-Amyloid (Aβ) and Human Cathelicidin LL-37: Two Sides of the Same Coin?

Combined nonoxynol-9 and antimicrobial peptide LL-37 for barrier contraception.

Effects of Botulinum Toxin A on Rosacea-Like Inflammation in an LL-37-Induced Rosacea Mouse Model.

Aggregation-State Dynamics Drive Double Cooperativity Between Antimicrobial Peptides LL-37 and HNP1.

LL-37 selectively targets Plasmodium-infected erythrocytes and exhibits antimalarial activity.

Heteroaggregation of Antimicrobial Peptides LL-37 and HNP‑1 Drives Cooperative Neutralization of Cytotoxicity.

LL-37 IgG levels are associated with clinical characteristics and T follicular cell response in acute coronary syndrome in adults.

LL-37 Inhibits EV71 Infection by Upregulating STAC via the EGFR-ERK Signaling Pathway.

Adaptive immune response to the autoantigen LL‐37 differentiates atherosclerotic cardiovascular disease phenotypes

Dermofunctional Vehicle Downregulates LL-37 and MMPs and Upregulates IGFBP-3.

Serine protease HtrA promotes <i>Campylobacter jejuni</i> intestinal colonization through degrading antimicrobial peptide LL-37.

Comparing the genetic and serum expression of LL-37 Antimicrobial Peptide in pemphigus vulgaris and pemphigus foliaceus patients.

Evaluation of the relationship between salivary levels of Streptococcus mutans, statherin, and cathelicidin LL-37 and early childhood caries.

<i>Legionella pneumophila</i>-Induced NETs Do Not Bear LL-37 Peptides.

Assessment of Antimicrobial Activity of LL-37 Peptide Against Periapical Pathogens: A Cross-Sectional Study.

LL-37 and citrullinated-LL-37 modulate IL-17A/F-mediated responses and selectively suppress Lipocalin-2 in bronchial epithelial cells.

Optimized LL-37-Derived Peptides Exhibit Antitubercular Activity, Induce Membrane Disruption, and P-Type ATPase Transcriptional Responses in <i>Mycobacterium tuberculosis</i>.

Elevated LL-37/FPR2 Axis and its Regulatory Role for Gingival Fibroblasts in Periodontitis.

Structural and mechanistic divergence in LL-37, HNP-1, and Magainin-2: An integrated computational and biophysical analysis.

LAPTM5 exacerbates STING-mediated inflammation induced by LL-37 through stabilizing STING in rosacea.

A Comprehensive Summary of LL-37, the Factotum Human Cathelicidin Peptide

LL-37: Biological Mechanisms and Emerging Therapeutic Applications in Intestinal Disease.

Therapeutic effect of an MRGPRX2/MRGPRB2 antagonist on LL-37-induced rosacea-like inflammation in mice.

Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications.

The antibacterial effect of human adipose-derived stem cells on LL-37-resistant bacteria.

&lt;i&gt;LL-37&lt;/i&gt; as a biomarker for therapeutic response to scaling and root planing.

Design and Screening of the Peptide SAMP-12aa Derived from LL-37, Which Exhibits Anti-&lt;i&gt;H. Pylori&lt;/i&gt; Activity and Immunomodulatory Effects.

LL-37-biofunctionalized titanium improves soft tissue seal surrounding the dental implant from the perspective of optimizing a race to the surface.

LL-37 and citrullinated-LL-37 enhances oxylipins: citrullination attenuates LL-37-mediated COX-2-dependent chemokine response in human bronchial epithelial cells.

β-Amyloid (Aβ) and Human Cathelicidin LL-37: Two Sides of the Same Coin?

Combined nonoxynol-9 and antimicrobial peptide LL-37 for barrier contraception.

Effects of Botulinum Toxin A on Rosacea-Like Inflammation in an LL-37-Induced Rosacea Mouse Model.

Aggregation-State Dynamics Drive Double Cooperativity Between Antimicrobial Peptides LL-37 and HNP1.

LL-37 selectively targets Plasmodium-infected erythrocytes and exhibits antimalarial activity.

Heteroaggregation of Antimicrobial Peptides LL-37 and HNP‑1 Drives Cooperative Neutralization of Cytotoxicity.

LL-37 IgG levels are associated with clinical characteristics and T follicular cell response in acute coronary syndrome in adults.

LL-37 Inhibits EV71 Infection by Upregulating STAC via the EGFR-ERK Signaling Pathway.

Adaptive immune response to the autoantigen LL‐37 differentiates atherosclerotic cardiovascular disease phenotypes

Dermofunctional Vehicle Downregulates LL-37 and MMPs and Upregulates IGFBP-3.

Serine protease HtrA promotes &lt;i&gt;Campylobacter jejuni&lt;/i&gt; intestinal colonization through degrading antimicrobial peptide LL-37.

Comparing the genetic and serum expression of LL-37 Antimicrobial Peptide in pemphigus vulgaris and pemphigus foliaceus patients.

Evaluation of the relationship between salivary levels of Streptococcus mutans, statherin, and cathelicidin LL-37 and early childhood caries.

&lt;i&gt;Legionella pneumophila&lt;/i&gt;-Induced NETs Do Not Bear LL-37 Peptides.

Assessment of Antimicrobial Activity of LL-37 Peptide Against Periapical Pathogens: A Cross-Sectional Study.

LL-37 and citrullinated-LL-37 modulate IL-17A/F-mediated responses and selectively suppress Lipocalin-2 in bronchial epithelial cells.

Optimized LL-37-Derived Peptides Exhibit Antitubercular Activity, Induce Membrane Disruption, and P-Type ATPase Transcriptional Responses in &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt;.

Elevated LL-37/FPR2 Axis and its Regulatory Role for Gingival Fibroblasts in Periodontitis.

Structural and mechanistic divergence in LL-37, HNP-1, and Magainin-2: An integrated computational and biophysical analysis.

LAPTM5 exacerbates STING-mediated inflammation induced by LL-37 through stabilizing STING in rosacea.

<i>LL-37</i> as a biomarker for therapeutic response to scaling and root planing.

Design and Screening of the Peptide SAMP-12aa Derived from LL-37, Which Exhibits Anti-<i>H. Pylori</i> Activity and Immunomodulatory Effects.

Serine protease HtrA promotes <i>Campylobacter jejuni</i> intestinal colonization through degrading antimicrobial peptide LL-37.

<i>Legionella pneumophila</i>-Induced NETs Do Not Bear LL-37 Peptides.

Optimized LL-37-Derived Peptides Exhibit Antitubercular Activity, Induce Membrane Disruption, and P-Type ATPase Transcriptional Responses in <i>Mycobacterium tuberculosis</i>.